4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-18-021481
VP and Chief Compliance Office acquired 3,000 shares (grant or award)
- VP and Chief Compliance Office gave up 2,999 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Herman James L VP and Chief Compliance Office | 2018-03-23 | Grant or award | +3,000 | $6.70 | $20,100 | 45,948 | D |
| Herman James L VP and Chief Compliance Office | 2018-03-23 | Shares withheld for taxes | −2,999 | $6.70 | $20,093 | 42,949 | D |
Loading xslF345X03/doc4.xml…